TuisCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
Vorige sluiting
$148,87
Dagwisseling
$149,03 - $154,01
Jaarwisseling
$91,86 - $230,02
Markkapitalisasie
7,49 mjd USD
Gemiddelde volume
880,66 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NYSE
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 1,03 mjd | 0,59% |
Bedryfskoste | 211,51 m | 8,67% |
Netto inkomste | 52,33 m | -44,38% |
Netto winsgrens | 5,07 | -44,71% |
Wins per aandeel | 3,12 | 11,43% |
EBITDA | 327,04 m | 26,18% |
Effektiewe belastingkoers | 26,22% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 182,82 m | 2,01% |
Totale bates | 7,56 mjd | -4,88% |
Totale aanspreeklikheid | 4,16 mjd | -0,34% |
Totale ekwiteit | 3,40 mjd | — |
Uitstaande aandele | 49,21 m | — |
Prys om te bespreek | 2,18 | — |
Opbrengs op bates | 5,68% | — |
Opbrengs op kapitaal | 6,93% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 52,33 m | -44,38% |
Kontant van bedrywe | 204,60 m | 5,72% |
Kontant van beleggings | -37,34 m | 39,65% |
Kontant van finansiering | -226,92 m | 20,62% |
Netto kontantverandering | -46,99 m | 70,17% |
Beskikbare kontantvloei | 228,38 m | 54,82% |
Meer oor
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in preclinical and clinical laboratory, gene therapy and cell therapy services and supplies for the pharmaceutical, medical device and biotechnology industries.
The company has over 150 facilities, operates in 21 countries, and employs over 21,000 people worldwide.
Charles River Laboratories frequently criticized by animal rights activists, who condemn the company's use of dogs and primates for pharmaceutical research. The company is also a major harvester of blood from horseshoe crabs. Wikipedia
Gestig
1947
Webwerf
Werknemers
19 400
